NEURO-ONCOLOGY CENTRES IN CHINA
FOR INTERNATIONAL PATIENTS
China's top neurosurgery and neuro-oncology centres treat more brain tumour patients annually than most countries' entire national programmes โ with advanced modalities, molecular tumour boards, and clinical trial access that rival the best Western institutions.
analyticsAt a Glance
- check_circleTiantan Hospital: China's most famous dedicated neuroscience institution โ 5,000+ brain tumour cases annually
- check_circleXuanwu Hospital: highest-volume awake craniotomy and fluorescence-guided GBM resection
- check_circleXiamen Humanity Hospital: China's most active BNCT programme for recurrent GBM
- check_circleAll centres accessible through CancerFax with Mandarin-English coordination
China's Leading Neuro-Oncology Centres: Comparison
Key features of China's top brain tumour treatment institutions for international patients โ helping match the right centre to your diagnosis and treatment need.
| Centre | City | Key Strengths | Advanced Modalities | International Patient Support |
|---|---|---|---|---|
| Tiantan Hospital (Capital Medical University) | Beijing | Dedicated neuroscience; 5,000+ brain tumours/yr; comprehensive MDT | SRS, TTFields, CAR-T trials, molecular tumour board | International department; English coordinators; visa support |
| Xuanwu Hospital (Capital Medical University) | Beijing | Highest awake craniotomy and 5-ALA fluorescence surgery volume in China | Intraoperative MRI, awake craniotomy, fluorescence resection, SBRT | International patient unit; English-speaking neurosurgeons |
| Huashan Hospital (Fudan University) | Shanghai | National reputation for complex brain tumour resection; strong molecular programme | Molecular tumour board, BNCT referral, proton therapy access (SPHIC) | International centre; English support; FUSCC integration |
| Zhongshan Hospital (Fudan University) | Shanghai | Comprehensive oncology; strong neuro-oncology-medical oncology integration | Systemic therapy, immunotherapy trials, radiation oncology | Established international patient programme |
| Xiamen Humanity Hospital | Xiamen | China's most active BNCT centre โ recurrent GBM and H&N cancer | Accelerator-based BNCT โ only modality at this centre for neuro-oncology | Accepts international BNCT candidates; CancerFax coordination available |
| PUMCH (Peking Union Medical College Hospital) | Beijing | China's most prestigious academic medical centre; neurosurgery + medical oncology | Full spectrum; CAR-T trial access; genomic tumour board | Established international patient pathway; English-speaking oncologists |
Which Centre Is Right for Your Case?
The optimal Chinese neuro-oncology centre depends on your diagnosis, what you need from the visit, and your disease stage. CancerFax matches patients to centres based on clinical fit, not convenience.
For Complex Neurosurgery
Xuanwu Hospital โ if you need awake craniotomy for eloquent cortex tumour, 5-ALA fluorescence-guided GBM resection, or intraoperative MRI-guided resection, Xuanwu has the highest volume of these specialised procedures in China. Tiantan Hospital is the alternative for a comprehensive MDT and broader neuro-oncology programme alongside surgery.
For BNCT Access
Xiamen Humanity Hospital is the dedicated destination for recurrent GBM or head and neck cancer patients seeking BNCT. This is the only Chinese centre with consistent BNCT clinical volumes for international patients. CancerFax performs BNCT eligibility review (BPA uptake suitability, prior RT history, performance status) before recommending travel to Xiamen.
For Clinical Trial Access
PUMCH and Tiantan Hospital have the broadest GBM clinical trial portfolios โ CAR-T, neoantigen vaccines, oncolytic virus, and novel combination immunotherapy. Trial eligibility depends on molecular profile (MGMT, EGFR, IDH, TMB) and prior treatment history. CancerFax performs systematic trial matching before any centre recommendation.
For Comprehensive MDT + Systemic Therapy
Huashan (Shanghai) or PUMCH (Beijing) for cases where integrated medical oncology โ systemic chemotherapy, targeted therapy, immunotherapy โ alongside neurosurgery and radiation oncology is needed in a single centre environment. Both have molecular tumour boards that discuss each GBM case.
Accessing Neuro-Oncology Care in China: The Process
The typical timeline from first contact to first consultation or treatment is 3โ5 weeks โ understanding each step reduces uncertainty.
- 1
Step 1: Upload Brain MRI and Records
MRI brain with contrast (T1 + T2 + FLAIR + perfusion + spectroscopy if available) in DICOM format; pathology report with WHO grade and molecular markers; operative report if prior surgery; prior RT records; current medications and performance status assessment.
- 2
Step 2: Neuro-Oncology Review
CancerFax's team reviews records and identifies: most appropriate Chinese centre for your diagnosis and treatment need; BNCT eligibility if recurrent post-RT; trial eligibility based on molecular profile; and whether additional molecular testing is needed before a centre can provide a meaningful consultation.
- 3
Step 3: Cost Estimate
Written cost estimates from the recommended Chinese centre(s) โ covering neurosurgical consultation, planned surgery or treatment, hospital stay, and post-operative imaging. For trial participation, treatment cost is typically $0 (sponsor-funded); ancillary costs (hotel, flights) are patient-funded.
- 4
Step 4: Visa and Travel Coordination
CancerFax provides the hospital invitation letter for Chinese medical visa. Visa processing: 10โ20 business days. Accommodation near Tiantan (Fengtai district, Beijing) or Huashan (Jing'an district, Shanghai) coordinated. Interpreter support arranged for all clinical consultations.
- 5
Step 5: Consultation, Treatment, and Follow-Up
Neuro-oncology MDT consultation on arrival. Treatment plan confirmed. Surgery, BNCT, or trial entry initiated. Discharge documentation translated and sent to home oncologist within 7 days of discharge. Post-treatment imaging review coordinated with CancerFax.
China vs India for Brain Tumour Treatment
Both China and India offer high-quality neuro-oncology care at significantly lower cost than the West โ each has distinct strengths for specific diagnoses.
China Strengths (Neuro-Oncology)
- BNCT โ only accessible option in Asia outside JapanXiamen's BNCT programme is the most active in China โ critical for recurrent GBM or H&N cancer post-RT
- CAR-T and oncolytic virus clinical trialsMost active GBM investigational trial portfolio in Asia โ Phase I/II trials enrolling now
- Highest GBM neurosurgery volume in AsiaTiantan and Xuanwu collectively perform more brain tumour operations than most countries
- Molecular tumour board standard at major centresWeekly MDT with neuro-oncology, neurosurgery, radiation oncology, and molecular pathology
India Strengths (Neuro-Oncology)
- Full English-language careAll major Indian neuro-oncology centres (CMC Vellore, NIMHANS, Tata Memorial) operate in English without interpreter requirement
- Proton therapy (Apollo Proton Centre Chennai)The only proton centre in South Asia โ preferred for paediatric brain tumours, skull-base tumours, and re-irradiation
- Simpler visa and travel logisticsIndian medical visa process is faster and logistically simpler for most nationalities than China
- SRS and SBRT widely availableGamma Knife, CyberKnife, and linear accelerator-based SRS at multiple Indian academic and private centres
Related Neuro-Oncology Resources
Further guides on brain tumour treatment options and access.
Frequently Asked Questions
Neuro-Oncology Centres in China
Do Chinese neuro-oncologists speak English?
At major academic centres โ Tiantan, Xuanwu, Huashan, and PUMCH โ many senior neurosurgeons and neuro-oncologists have international training or academic collaborations and are English-proficient. All centres have international patient departments with English-speaking coordinators and medical interpreters. CancerFax provides additional Mandarin-English clinical coordination throughout the process โ ensuring all consent discussions, treatment planning conversations, and discharge instructions are fully understood by international patients and their families.
How do I choose between Tiantan Hospital and Xuanwu Hospital for GBM?
Both are excellent choices for GBM in Beijing. Tiantan Hospital is better suited for patients who want a comprehensive neuro-oncology MDT, trial access, and a broad multi-specialty programme in one institution. Xuanwu Hospital is the preferred choice for patients specifically seeking maximal safe resection with awake craniotomy, 5-ALA fluorescence-guided surgery, or intraoperative MRI โ where Xuanwu's surgical volume and expertise is the highest in China. CancerFax reviews your specific case and makes a personalised recommendation based on what you need from the Chinese visit.
How long do I need to stay in China for GBM treatment?
For neurosurgery alone: 2โ3 weeks (operation + post-operative recovery + discharge). For the full Stupp protocol (surgery + concurrent RT + TMZ): 8โ10 weeks. For BNCT: 1 week total (2 days pre-treatment preparation, 1 day treatment, 2โ3 days observation post-BNCT). For clinical trial participation: varies by trial โ CancerFax provides the specific visit schedule for each protocol. Adjuvant TMZ cycles after the concurrent phase can often be administered at a local centre in your home country with records reviewed remotely by the Chinese team.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Looking for Neuro-Oncology Care in China?
Upload your brain MRI, pathology, and treatment history. CancerFax will match you to the most appropriate Chinese centre based on your diagnosis and treatment need.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.